Search research articles
Contact Us
Filters
Showing results (21-30 of 64) with videos related to
Page
of 7
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 11, 2008
Role of mitogen-activated protein kinases in tauroursodeoxycholic acid-induced bile formation in cholestatic rat liver
Gerald Ulrich Denk, Simon Hohenester, Ralf Wimmer, et al.
Journal of Hepatology
|
March 4, 2008
High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective
Susan N Cullen, Christian Rust, Kenneth Fleming, et al.
Biochemical and Biophysical Research Communications
|
May 3, 2008
Free fatty acids sensitize hepatocytes to bile acid-induced apoptosis
Thomas Pusl, Nadine Wild, Timo Vennegeerts, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 24, 2014
Soluble intracellular adhesion molecule, M30 and M65 as serum markers of disease activity and prognosis in cholestatic liver diseases
Gerald Denk, Ahmed-Jawid Omary, Florian Paul Reiter, et al.
Journal of Hepatology
|
August 3, 2010
Phosphatidylinositol-3-kinase p110γ contributes to bile salt-induced apoptosis in primary rat hepatocytes and human hepatoma cells
Simon Hohenester, Anna Gates, Ralf Wimmer, et al.
Clinical Pharmacology in Drug Development
|
April 29, 2016
Therapeutic Equivalence of Ursodeoxycholic Acid Tablets and Ursodeoxycholic Acid Capsules for the Treatment of Primary Biliary Cirrhosis
Corinna Hopf, Renate Grieshaber, Heinz Hartmann, et al.
The Journal of Biological Chemistry
|
March 11, 2003
Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets
Ulrich Beuers, Gerald U Denk, Carol J Soroka, et al.
Journal of Hepatology
|
March 15, 2012
Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health
Karin Dilger, Simon Hohenester, Ursula Winkler-Budenhofer, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
June 8, 2018
Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis
Simon Hohenester, Simon Christiansen, Jutta Nagel, et al.
Digestion
|
February 10, 2011
Analysis of IL2/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis
Johannes Stallhofer, Gerald Ulrich Denk, Jürgen Glas, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 64) with videos related to
Sort By:
Page
of 7
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 11, 2008
Role of mitogen-activated protein kinases in tauroursodeoxycholic acid-induced bile formation in cholestatic rat liver
Gerald Ulrich Denk, Simon Hohenester, Ralf Wimmer, et al.
Journal of Hepatology
|
March 4, 2008
High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective
Susan N Cullen, Christian Rust, Kenneth Fleming, et al.
Biochemical and Biophysical Research Communications
|
May 3, 2008
Free fatty acids sensitize hepatocytes to bile acid-induced apoptosis
Thomas Pusl, Nadine Wild, Timo Vennegeerts, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 24, 2014
Soluble intracellular adhesion molecule, M30 and M65 as serum markers of disease activity and prognosis in cholestatic liver diseases
Gerald Denk, Ahmed-Jawid Omary, Florian Paul Reiter, et al.
Journal of Hepatology
|
August 3, 2010
Phosphatidylinositol-3-kinase p110γ contributes to bile salt-induced apoptosis in primary rat hepatocytes and human hepatoma cells
Simon Hohenester, Anna Gates, Ralf Wimmer, et al.
Clinical Pharmacology in Drug Development
|
April 29, 2016
Therapeutic Equivalence of Ursodeoxycholic Acid Tablets and Ursodeoxycholic Acid Capsules for the Treatment of Primary Biliary Cirrhosis
Corinna Hopf, Renate Grieshaber, Heinz Hartmann, et al.
The Journal of Biological Chemistry
|
March 11, 2003
Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets
Ulrich Beuers, Gerald U Denk, Carol J Soroka, et al.
Journal of Hepatology
|
March 15, 2012
Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health
Karin Dilger, Simon Hohenester, Ursula Winkler-Budenhofer, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
June 8, 2018
Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis
Simon Hohenester, Simon Christiansen, Jutta Nagel, et al.
Digestion
|
February 10, 2011
Analysis of IL2/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis
Johannes Stallhofer, Gerald Ulrich Denk, Jürgen Glas, et al.
Page
of 7